Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Qualigen Therapeutics ( (QLGN) ) has issued an update.
Graydon Bensler has been appointed as an independent board member, bringing over seven years of financial consulting and management experience. A Chartered Financial Analyst, Bensler co-founded an Ed Tech company and held key roles in investor relations and investment banking. His expertise in capital markets and public company compliance is expected to benefit the board significantly.
See more data about QLGN stock on TipRanks’ Stock Analysis page.
